Company / Profit Margin
Charles River Laboratories Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3.6%
FY2025
5-year range
-3.6% / 12.5%
FY2021-FY2025
Trend
-752.7%
vs FY2024
Sector context
#106 of 155
Health Care
What the data says
Profit Margin changed -753% YoY in FY2025, a notable deviation from the 9-year average annual change of -76%.
Based on SEC 10-K filings.
-3.6% in FY2025 with a 5-year CAGR of -13.6%.
Declined from 11.0% to -3.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -16.1pp
- 5-Year Change
- -13.6pp
- 10-Year Change
- -
Sector benchmark
#106 of 155 in Health CareTop 68% of 155This company -3.6% Sector average -254.2%
▼
+98.6% above sector average
Key checks
Key Insights
- Charles River Laboratories's profit margin has declined for 3 consecutive years.
- In FY2025, profit margin decreased 752.7% year-over-year.
- Currently 250.6pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.6% | -752.7% |
| FY2024 | 0.5% | -95.0% |
| FY2023 | 11.0% | -11.4% |
| FY2022 | 12.5% | +29.7% |
| FY2021 | 9.6% | -3.8% |
| FY2020 | 10.0% | +50.5% |
| FY2019 | 6.6% | -33.5% |
| FY2018 | 10.0% | -63.9% |
| FY2017 | 27.7% | +200.8% |
| FY2016 | 9.2% | +4.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026